From the Department of Anaesthesia and Intensive Care, the Chinese University of Hong Kong, Hong Kong, China.
Department of Health Technology and Informatics, the Hong Kong Polytechnic University, Hong Kong, China.
Anesth Analg. 2018 Jun;126(6):1989-1994. doi: 10.1213/ANE.0000000000002243.
The use of norepinephrine for maintaining blood pressure (BP) during spinal anesthesia for cesarean delivery has been described recently. However, its administration by titrated manually controlled infusion in this context has not been evaluated.
In a double-blinded, randomized controlled trial, 110 healthy women having spinal anesthesia for elective cesarean delivery were randomly allocated to 1 of 2 groups. In group 1, patients received an infusion of 5 µg/mL norepinephrine that was started at 30 mL/h (2.5 µg/min) immediately after intrathecal injection and then manually adjusted within the range 0-60 mL/h (0-5 µg/min), according to values of systolic BP measured noninvasively at 1-minute intervals until delivery, with the objective of maintaining values near baseline. In group 2, no prophylactic vasopressor was given, and a bolus of 1 mL norepinephrine 5 µg/mL (5 µg) was given whenever systolic BP decreased to <80% of the baseline value. The study protocol was continued until delivery. The primary outcomes of the study were the incidence of hypotension and the overall stability of systolic BP control versus baseline compared using performance error calculations. In addition, the incidence and timing of hypotension were further compared using survival analysis.
Three patients were excluded from the analysis. Nine patients (17%) in group 1 had 1 or more episodes of hypotension versus 35 (66%) in group 2 (P < .001). Performance error calculations showed that on average, systolic BP was maintained closer to baseline (P < .001) in group 1. Survival curve analysis showed a significant difference between groups (log-rank test P < .001). Four patients in each group had a recorded heart rate <60 beats/min (P = .98). Despite a much greater rate of administration of norepinephrine in group 1 (median, 61.0 [interquartile range, 47.0-72.5] µg) versus group 2 (5.0 [0-18.1] µg) (P < .001), there was no difference in neonatal outcome as assessed by Apgar scores and umbilical cord blood gas analysis.
In patients having spinal anesthesia for elective cesarean delivery, a manually titrated infusion of 5 µg/mL of norepinephrine was effective for maintaining BP and decreasing the incidence of hypotension, with no detectable detrimental effect on neonatal outcome. Further investigation of the use of dilute norepinephrine infusions for routine use in obstetric patients is suggested.
最近有研究描述了去甲肾上腺素在剖宫产椎管内麻醉中用于维持血压(BP)的应用。然而,在这种情况下,通过滴定手动控制输注来给药尚未得到评估。
在一项双盲、随机对照试验中,110 名接受择期剖宫产的健康女性被随机分为 2 组。在第 1 组中,患者在鞘内注射后立即开始输注 5µg/mL 的去甲肾上腺素,输注速度为 30mL/h(2.5µg/min),然后根据非侵入性测量的 1 分钟间隔收缩压值手动调整输注速度,范围为 0-60mL/h(0-5µg/min),目标是将收缩压值维持在接近基线的水平。在第 2 组中,未给予预防性血管加压药,当收缩压降至基线值的 <80%时,给予 1 毫升 5µg/mL 去甲肾上腺素(5µg)的推注。研究方案一直持续到分娩。该研究的主要结局是使用性能误差计算比较低血压的发生率和收缩压与基线相比的整体稳定性。此外,还使用生存分析进一步比较了低血压的发生率和时间。
3 名患者被排除在分析之外。第 1 组中有 9 名(17%)患者发生 1 次或多次低血压,而第 2 组中有 35 名(66%)患者发生低血压(P<.001)。性能误差计算显示,收缩压平均更接近基线(P<.001)。生存曲线分析显示两组之间存在显著差异(对数秩检验 P<.001)。两组各有 4 名患者的心率<60 次/分钟(P=0.98)。尽管第 1 组(中位数,61.0[四分位间距,47.0-72.5]µg)的去甲肾上腺素给药率明显高于第 2 组(5.0[0-18.1]µg)(P<.001),但新生儿结局(通过 Apgar 评分和脐血血气分析评估)无差异。
在接受择期剖宫产的患者中,手动滴定输注 5µg/mL 的去甲肾上腺素可有效维持血压并降低低血压的发生率,且对新生儿结局无明显不良影响。建议进一步研究在产科患者中常规使用稀释的去甲肾上腺素输注。